CymaBay Therapeutics, Inc.

Assenagon Asset Management S.A.

Report date

12/31/2023

Quarter

2023 Q4

Filed

1/17/2024

Shares

746,353

Value ($000)

17,629

Weight

0.1%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	1/17/2024	17,629	0.1%	746,353	12/31/2023